Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Irvin

Irvin Chen, San Jose, CA US

Patent application numberDescriptionPublished
20110067600Methods and compositions using calcium carbonate - Provided herein are compositions and methods including hydraulic cement, supplementary cementitious material, and/or self-cementing material. Methods for making the compositions and using the compositions are provided.03-24-2011
20110067603Methods and compositions using calcium carbonate - Provided herein are compositions and methods including hydraulic cement, supplementary cementitious material, and/or self-cementing material. Methods for making the compositions and using the compositions are provided.03-24-2011
20110203489METHODS AND COMPOSITIONS USING CALCIUM CARBONATE - Provided herein are compositions and methods including hydraulic cement, supplementary cementitious material, and/or self-cementing material. Methods for making the compositions and using the compositions are provided.08-25-2011

Irvin Ebaugh, Ocean City, MD US

Patent application numberDescriptionPublished
20110302856PROTECTION SYSTEM FOR STRUCTURAL MEMBERS SUCH AS CABLES - A protection system for a structural element is provided. The protection system employs a shield assembly comprising two parts formed of one or more materials configured to provide protection from a threat, such as a blast, projectiles, cutting, or a fire. At least one bracket assembly attaches to the structural element. The shield assembly is hingedly attached to the bracket assembly, so that the two parts of the shield assembly can be moved away from the structural element while remaining attached to the structural element.12-15-2011

Irvin Krukenkamp, South Berwick, ME US

Patent application numberDescriptionPublished
20100048650TWO PORE CHANNELS AS A THERAPEUTIC TARGET TO PROTECT AGAINST MYOCARDIAL ISCHEMIA AND AS AN ADJUVANT IN CARDIAC SURGERY - The present invention relates to methods and compositions for modulating the activity of two-pore domain K+ channels (“K2P channels”) as a means for inducing preconditioning protection. Such preconditioning can be used to reduce the effect of ischemia associated with ischemic heart disease, myocardial infarcation or cardiac surgery. The invention is based on the discovery that the myoprotective current induced by short periods of ischemia is carried by a non-classical two-pore domain K+ channel.02-25-2010

Irvin Vanderpohl, Greensburg, IN US

Patent application numberDescriptionPublished
20080224861HOSPITAL BED HAVING WIRELESS DATA CAPABILITY - A system is provided for use with a pre-existing hospital bed and a nurse call system. The system includes a first apparatus that is coupleable to a data port of the hospital bed and a second apparatus that is spaced from the hospital bed, that is spaced from the first apparatus, and that is coupleable to the nurse call system. A transmitter of the first apparatus is operable to transmit data received at the data port to a receiver that is operable to wirelessly receive data transmitted by the wireless transmitter of the first apparatus. The first apparatus and second apparatus are used in lieu of a cable that is otherwise usable to connect the hospital bed to the nurse call system via a hard-wired connection.09-18-2008

Irvin Winkler, Liederbach DE

Patent application numberDescriptionPublished
20090215728Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use - This invention relates to arylaminoaryl-alkyl-substituted imidazolidone-2,4-diones of formula (I) and also to their physiologically tolerated salts:08-27-2009
20090298904NOVEL PEPTIDES FROM ACTINOMADURA NAMIBIENSIS - The disclosure relates to a compound of the formula (I)12-03-2009
20110046105Heterocycle-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising them and use thereof - The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.02-24-2011
20110046185Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof - The invention relates to compounds of formula (I) wherein the groups R and R′ A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.02-24-2011
20110053947Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof - The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.03-03-2011
20110112097Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof - The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.05-12-2011
20110178134Novel phenyl-substituted imidazolidines, process for preparation thereof, medicaments comprising said compounds and use thereof - The invention relates to compounds of formula (I) wherein the groups have stated meanings, and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.07-21-2011